Arcus Biosciences Statistics
Total Valuation
RCUS has a market cap or net worth of $1.20 billion. The enterprise value is $407.80 million.
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RCUS has 106.43 million shares outstanding. The number of shares has increased by 18.59% in one year.
| Current Share Class | 106.43M |
| Shares Outstanding | 106.43M |
| Shares Change (YoY) | +18.59% |
| Shares Change (QoQ) | +8.23% |
| Owned by Insiders (%) | 4.40% |
| Owned by Institutions (%) | 58.73% |
| Float | 59.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.19 |
| Forward PS | 11.61 |
| PB Ratio | 2.19 |
| P/TBV Ratio | 2.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.50, with a Debt / Equity ratio of 0.24.
| Current Ratio | 4.50 |
| Quick Ratio | 4.43 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -56.33 |
Financial Efficiency
Return on equity (ROE) is -50.34% and return on invested capital (ROIC) is -28.88%.
| Return on Equity (ROE) | -50.34% |
| Return on Assets (ROA) | -18.69% |
| Return on Invested Capital (ROIC) | -28.88% |
| Return on Capital Employed (ROCE) | -39.08% |
| Revenue Per Employee | $417,863 |
| Profits Per Employee | -$475,279 |
| Employee Count | 627 |
| Asset Turnover | 0.23 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, RCUS has paid $1.00 million in taxes.
| Income Tax | 1.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.99% in the last 52 weeks. The beta is 0.83, so RCUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -27.99% |
| 50-Day Moving Average | 9.78 |
| 200-Day Moving Average | 10.84 |
| Relative Strength Index (RSI) | 60.47 |
| Average Volume (20 Days) | 775,456 |
Short Selling Information
The latest short interest is 9.10 million, so 8.55% of the outstanding shares have been sold short.
| Short Interest | 9.10M |
| Short Previous Month | 10.05M |
| Short % of Shares Out | 8.55% |
| Short % of Float | 15.19% |
| Short Ratio (days to cover) | 11.71 |
Income Statement
In the last 12 months, RCUS had revenue of $262.00 million and -$298.00 million in losses. Loss per share was -$3.07.
| Revenue | 262.00M |
| Gross Profit | -223.00M |
| Operating Income | -338.00M |
| Pretax Income | -246.00M |
| Net Income | -298.00M |
| EBITDA | -328.00M |
| EBIT | -338.00M |
| Loss Per Share | -$3.07 |
Full Income StatementBalance Sheet
The company has $911.00 million in cash and $130.00 million in debt, giving a net cash position of $797.00 million or $7.49 per share.
| Cash & Cash Equivalents | 911.00M |
| Total Debt | 130.00M |
| Net Cash | 797.00M |
| Net Cash Per Share | $7.49 |
| Equity (Book Value) | 549.00M |
| Book Value Per Share | 5.16 |
| Working Capital | 736.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$339.00 million and capital expenditures -$3.00 million, giving a free cash flow of -$342.00 million.
| Operating Cash Flow | -339.00M |
| Capital Expenditures | -3.00M |
| Free Cash Flow | -342.00M |
| FCF Per Share | -$3.21 |
Full Cash Flow StatementMargins
Gross margin is -85.11%, with operating and profit margins of -129.01% and -113.74%.
| Gross Margin | -85.11% |
| Operating Margin | -129.01% |
| Pretax Margin | -113.36% |
| Profit Margin | -113.74% |
| EBITDA Margin | -125.19% |
| EBIT Margin | -129.01% |
| FCF Margin | n/a |
Dividends & Yields
RCUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.59% |
| Shareholder Yield | -18.59% |
| Earnings Yield | -24.73% |
| FCF Yield | -28.39% |
Dividend DetailsAnalyst Forecast
The average price target for RCUS is $20.71, which is 82.95% higher than the current price. The consensus rating is "Buy".
| Price Target | $20.71 |
| Price Target Difference | 82.95% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 26.36% |
| EPS Growth Forecast (5Y) | -15.78% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RCUS has an Altman Z-Score of -0.17 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.17 |
| Piotroski F-Score | 1 |
